Medtronic Inc

MDT-N

Likes a lot of the big US healthcare stocks. Valuation is reasonable.

On his watch list as a possible investment. Valuation has been hurt but the fundamentals have not changed much. The long-term outlook for their products is very good.

A high quality, growth company. Good price. The leading medical technology company in the world.

Solid earnings. Feels their new stent will be successful next year.

Interesting company. Market is very strong for their products. Stock isn't cheap. Has been growing slowely

Valuation is a little bit ahead of the stock. Very good management.

Competition. Too expensive at 30 X earnings.

Great company. Buy in the mid to low $20's.

Good company. Not a cheap stock. A cash machine.

Good price now. Good mngmnt.

Good acquisition. Fairly expensive, but the dominant player. No debt. Good dividends.

Just bought minimal. Cheap.

Decent price now. Buying a little now in mid-40's, but would buy a lot more in the 30's. Lots of cash.

Bullet proof portfolio-small caps(25%)

Has dropped from their highs.

No debt. Competition is large US companies, but they make money and the stock has grown. Good long term